Minimally invasive therapy of lower urinary tract symptoms
Abstract
The establishment of guidelines, pharmacologic therapies, improved understanding of lower urinary tract symptoms (LUTS) versus benign prostate hyperplasia (BPH), respect for patient-centered goals, and improved discrimination of the patient with occult prostate cancer have empowered change in the management of LUTS. These developments have allowed urologists to recognize the limitations of transurethral prostatectomy as the gold standard and search for "ideal therapies" to provide treatments with an improved relief of symptoms, decreased complication rate and cost, to correct BPH-associated morbidities and prevent future morbidities. Prognostic parameters and their ability to predict progression may be important in the future of LUTS management and selection of therapy.
References
Citations
Related Concepts
Related Feeds
Botulism (ASM)
Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.
Botulism
Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.
Bladder Carcinoma In Situ
Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.